← Pharmacists CPD
Enhancing Maternal Care: Best Practices in Managing Hypertensive Disorders during Pregnancy
Accreditation Details
Valid
From
18 Jun. 2026
18 Jun. 2026
Expiry
Date
31 Oct. 2026
31 Oct. 2026
CPD Points
2
2
CPD Category
Category 2
Category 2
Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements. Thank you for your cooperation and commitment to professional development.
Participation in this training is entirely voluntary, and you are free to opt out at any time. Please be assured that no personal information of any healthcare professional (HCP) will be shared with Ethypharm. Your privacy and confidentiality remain fully protected.
Hypertensive disorders remain a leading cause of maternal and perinatal morbidity worldwide. This accredited continuing professional development (CPD) convenes leading obstetricians, physicians, pharmacists, midwives and nurses to examine the latest evidence-based strategies for preventing, diagnosing and treating hypertension in pregnancy. Delivered in a dynamic hybrid format, the meeting blends live plenary teaching, real-time discussion and a focused product presentation introducing Ethypharm’s Magnesium Sulphate—a critical intervention in the management of severe gestational hypertension and eclampsia.
Participants will engage with a distinguished, multidisciplinary faculty who will translate cutting-edge research into practical bedside interventions, ensuring attendees leave equipped to improve maternal and neonatal outcomes in their own settings.
WHY YOU SHOULD ATTEND
i. Immediate clinical relevance – Gain concrete, guideline-aligned approaches you can apply on your next ward round or antenatal clinic.
ii. Earn CPD credits – Satisfy annual professional‐development requirements through an event vetted and accredited by the relevant councils.
iii. Interactive learning – Case vignettes, polling and Q&A ensure active participation, whether you join in person or online.
iv. Network across cadres – Forge vital connections with consultants, residents, pharmacists, midwives and policy makers committed to maternal safety.
EVENT HIGHLIGHTS
1. Keynote Session: “Enhancing Maternal Care—Best Practices in Managing Hypertensive Disorders During Pregnancy”
2. Multidisciplinary Panel: Obstetric physicians, clinical pharmacists and midwifery leaders debate real-world challenges and innovations
3. Case-Based Workshops: Interactive scenarios on triage, stabilization and magnesium-sulphate administration in resource-variable settings
4. In-Person Delivery: High-definition live-stream, on-demand replay and in-hall engagement tools for seamless participation
5. Accredited Certificate: Digital CPD certificate issued upon completion of post-event assessment and feedback
Secure your seat—whether on-site or online—and join us for an unmissable day devoted to safeguarding mothers and babies through excellence in hypertensive care.
PROUDLY ORGANIZED AND SPONSORED BY
This is an In-person event that will took place on Thursday the 18th of June 2026 at 4:00 pm.
Target Audience: Obstetricians & gynaecologists (consultants, specialists, residents), general medical practitioners, midwives, nurses, clinical pharmacists, and allied maternity-care professionals.
Moderator: Raymond Otu-Amanortey - Ethypharm Ghana
Date: Thursday 18th June 2026
Time: 1600 GMT (4:00 pm local time)
In-person attendance is STRICTLY BY INVITATION at the Golden Bean Hotel, Kumasi.
Overview
Course Description
This CPD brings together obstetricians, physicians, pharmacists and nurses to examine the latest evidence-based strategies for diagnosing and managing hypertensive disorders in pregnancy. Guided by an expert multidisciplinary faculty, participants will engage in interactive plenaries, case-based discussions and product-focused insights that translate cutting-edge research into practical bedside interventions, ultimately equipping them to improve maternal and neonatal outcomes in their own clinical settings.
What you will learn
By the end of the symposium, participants will be able to:
1. Describe the epidemiology, pathophysiology and classification of hypertensive disorders of pregnancy, including gestational hypertension, pre-eclampsia and eclampsia.
2. Apply current international and national guidelines to diagnose and stratify risk in pregnant patients presenting with hypertension.
3. Formulate individualized management plans integrating lifestyle modification, pharmacotherapy and timely referral or escalation of care.
4. Demonstrate correct dosing, administration and monitoring of Magnesium Sulphate, recognising indications, contraindications and adverse-event management.
5. Evaluate emerging evidence on adjunct therapies and biomarkers aimed at improving maternal and fetal outcomes.
6. Collaborate effectively within multidisciplinary teams to implement quality-improvement initiatives that reduce maternal mortality and morbidity related to hypertension.
Course Content
Lecture Sessions
No session added to this course yet.
Downloadables
No downloadable content added to this course yet.
Steps to Join Course
About Facilitator
- 1 Course on CES
Dr. Opei Kwafo Adarkwa
BSc, MB ChB, MGCPS, MPH,FGCS
Specialist Obstetrician and Gynaecologist | Part-Time Senior Lecturer
Manhyia District Hospital | Kwame Nkrumah University of Science and Technology.
Dr. Opei Kwafo Adarkwa is a Specialist Obstetrician and Gynaecologist at Manhyia District Hospital, where he also serves as Head of the Department of Obstetrics and Gynaecology and Co-Chair of the Centre for Research, Innovation and Development.
View full profile / coursesRelated Courses
